主方案：有效临床设计策略以拓展肿瘤药物和生物制品的开发（草案）

2018-10-03 美国食品和药品监督管理局 FDA

Docket Number:

中文标题：

英文标题：

Master Protocols: Efficient Clinical Trial Design Strategies To Expedite Development of Oncology Drugs and Biologics

发布机构：

美国食品和药品监督管理局

发布日期：

2018-10-03

简要介绍：

Docket Number:: FDA-2018-D-3292
Issued by:: Center for Drug Evaluation and Research

Center for Biologics Evaluation and Research

Oncology Center of Excellence

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics.” This guidance provides advice to sponsors of drugs and biologics for cancer treatment regarding the design and conduct of clinical trials, other than first-in-human (FIH) trials, intended to simultaneously evaluate more than one investigational drug and/or more than one cancer type within the same overall trial structure (master protocols) in adult and pediatric cancers. In contrast to traditional trial designs, where a single drug is tested in a single disease population in one clinical trial, master protocols use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple substudies, allowing for efficient and accelerated drug development.

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=af2bc1c0019e82c8, title=主方案：有效临床设计策略以拓展肿瘤药物和生物制品的开发（草案）, enTitle=Master Protocols: Efficient Clinical Trial Design Strategies To Expedite Development of Oncology Drugs and Biologics, guiderFrom=FDA, authorId=0, author=, summary=Docket Number:, cover=, journalId=0, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商，其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Wed Oct 03 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div class="inset-column" style="color: #333333;"> <dl class="lcds-description-list--grid"> <dt class="cell-1_1">Docket Number:</dt> <dd class="cell-2_1"><a style="color: #001871;" href="https://www.regulations.gov/docket?D=FDA-2018-D-3292">FDA-2018-D-3292</a></dd> <dt class="cell-1_2">Issued by:</dt> <dd class="cell-2_2"> <div class="field field--name-field-issuing-office-taxonomy field--type-entity-reference field--label-above"> <div class="field--items"> <div class="field--item">Center for Drug Evaluation and Research</div> <div class="field--item">Center for Biologics Evaluation and Research</div> <div class="field--item">Oncology Center of Excellence</div> </div> </div> </dd> </dl> </div> <p style="color: #333333;">The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics.” This guidance provides advice to sponsors of drugs and biologics for cancer treatment regarding the design and conduct of clinical trials, other than first-in-human (FIH) trials, intended to simultaneously evaluate more than one investigational drug and/or more than one cancer type within the same overall trial structure (master protocols) in adult and pediatric cancers. In contrast to traditional trial designs, where a single drug is tested in a single disease population in one clinical trial, master protocols use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple substudies, allowing for efficient and accelerated drug development.</p>, tagList=[TagDto(tagId=109, tagName=临床试验), TagDto(tagId=119, tagName=肿瘤), TagDto(tagId=18528, tagName=研究设计)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1776, appHits=42, showAppHits=0, pcHits=477, showPcHits=1734, likes=0, shares=7, comments=0, approvalStatus=1, publishedTime=Sun Sep 27 18:12:15 CST 2020, publishedTimeString=2018-10-03, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Sep 27 18:10:13 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 01:05:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])